Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Online Communities Help Caregivers Find Support, Save Time

    The Michael J. Fox Foundation Kicks Off New Online Event Series on Parkinson’s R&D

    Our new series of digital events, the Parkinson’s Disease Therapeutics Webinars, are free and feature presentations and discussions from leaders in Parkinson’s research and therapeutic development.
    Learn more
  • Kynmobi films and foils

    Supported by Early MJFF Investments, New Parkinson’s “Off” Therapy Receives Regulatory Approval

    The FDA recently approved a new Parkinson's medication — the second this year and the second MJFF funding made possible — for as-needed treatment of “off” time, when symptoms return between…
    Learn more
  • ogden 2016_lab test tube

    News in Context: One-Patient Parkinson’s Stem Cell Trial

    A “first of its kind” Parkinson’s stem cell trial recently reported data. Experts talk about the trial, results and future of PD stem cell research.

    Learn more
  • Person on a laptop using Fox Trial Finder.

    Ways to Advance Parkinson’s Research Online During COVID-19

    While some clinical trials have paused, there are still opportunities to contribute and advance Parkinson’s research from home.
    Learn more
  • A Note from Our CEO: Partnerships Foster Progress

    Our CEO on the Importance of Partnerships in Drug Research

    Our CEO Todd Sherer talks to the Foundation for the National Institutes of Health (FNIH) about the Accelerating Medicines Partnership for Parkinson’s Disease (AMP PD).
    Learn more
  • New Collaboration Seeks to Incorporate Patient Feedback into Clinical Trials

    News in Context: The PASADENA Study

    We talk to representatives from Roche and Prothena about the results of the PASADENA clinical trial of a potential Parkinson's therapy targeting alpha-synuclein.
    Learn more
  • Beakers lined up.

    Newly Approved Parkinson’s Drug Aims to Lessen “Off” Time

    The FDA approved a new Parkinson’s medication that works with levodopa to give better symptom control and less “off” time throughout the day.
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.
Here. Until Parkinson's isn't.
Join us as we work to find a cure for the 6 million people worldwide living with Parkinson's.
 
 
 
 
Month
Day
Year